Review




Structured Review

PeproTech rhil-3
Rhil 3, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhil-3/product/PeproTech
Average 90 stars, based on 1 article reviews
rhil-3 - by Bioz Stars, 2026-06
90/100 stars

Images



Similar Products

96
R&D Systems bt tpo rhil 3 r d systems
Bt Tpo Rhil 3 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt tpo rhil 3 r d systems/product/R&D Systems
Average 96 stars, based on 1 article reviews
bt tpo rhil 3 r d systems - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

93
R&D Systems rhil 11
Rhil 11, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhil 11/product/R&D Systems
Average 93 stars, based on 1 article reviews
rhil 11 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
PeproTech rhil-3
Rhil 3, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhil-3/product/PeproTech
Average 90 stars, based on 1 article reviews
rhil-3 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
PeproTech recombinant human il-3 rhil-3
Recombinant Human Il 3 Rhil 3, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il-3 rhil-3/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant human il-3 rhil-3 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

93
R&D Systems rhil 3
Rhil 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhil 3/product/R&D Systems
Average 93 stars, based on 1 article reviews
rhil 3 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
R&D Systems cytokines rhil 3
Cytokines Rhil 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytokines rhil 3/product/R&D Systems
Average 96 stars, based on 1 article reviews
cytokines rhil 3 - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
R&D Systems recombinant human il 37b rhil 37b
Fig. 1 IL-37 treatment ameliorated EAE at both priming and ongoing phases. (A) C57BL/6 mice were immunized to induce EAE and treated i.p. with IL-37 (1 µg/ dose; n = 5) and PBS (n = 4) at days 1, 4, and 7 p.i. The clinical scores were evaluated daily for 21 days p.i. Mean clinical scores for IL-37-treated and PBS-treated groups were calculated as the sum of daily scores for each mouse divided by the number of days per group. (B-C) EAE mice were treated i.p. with 1 µg of <t>rhIL-37b/</t> day when they showed the first symptoms of EAE. PBS was administered i.p. to the control group in the same way. Clinical scores were followed for 20 days p.i. (peak; n = 7 per group) (B) and 26 days p.i. (chronic; n = 4 per group) (C), and mean clinical scores were compared between IL-37-treated mice and control. Clinical scores were analyzed by multiple unpaired t-tests. Mean clinical scores were analyzed by Student’s t-test. Data shown as mean ± SEM. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered significant. Ns: not significant
Recombinant Human Il 37b Rhil 37b, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il 37b rhil 37b/product/R&D Systems
Average 96 stars, based on 1 article reviews
recombinant human il 37b rhil 37b - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 IL-37 treatment ameliorated EAE at both priming and ongoing phases. (A) C57BL/6 mice were immunized to induce EAE and treated i.p. with IL-37 (1 µg/ dose; n = 5) and PBS (n = 4) at days 1, 4, and 7 p.i. The clinical scores were evaluated daily for 21 days p.i. Mean clinical scores for IL-37-treated and PBS-treated groups were calculated as the sum of daily scores for each mouse divided by the number of days per group. (B-C) EAE mice were treated i.p. with 1 µg of rhIL-37b/ day when they showed the first symptoms of EAE. PBS was administered i.p. to the control group in the same way. Clinical scores were followed for 20 days p.i. (peak; n = 7 per group) (B) and 26 days p.i. (chronic; n = 4 per group) (C), and mean clinical scores were compared between IL-37-treated mice and control. Clinical scores were analyzed by multiple unpaired t-tests. Mean clinical scores were analyzed by Student’s t-test. Data shown as mean ± SEM. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered significant. Ns: not significant

Journal: Journal of neuroinflammation

Article Title: IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production.

doi: 10.1186/s12974-024-03295-1

Figure Lengend Snippet: Fig. 1 IL-37 treatment ameliorated EAE at both priming and ongoing phases. (A) C57BL/6 mice were immunized to induce EAE and treated i.p. with IL-37 (1 µg/ dose; n = 5) and PBS (n = 4) at days 1, 4, and 7 p.i. The clinical scores were evaluated daily for 21 days p.i. Mean clinical scores for IL-37-treated and PBS-treated groups were calculated as the sum of daily scores for each mouse divided by the number of days per group. (B-C) EAE mice were treated i.p. with 1 µg of rhIL-37b/ day when they showed the first symptoms of EAE. PBS was administered i.p. to the control group in the same way. Clinical scores were followed for 20 days p.i. (peak; n = 7 per group) (B) and 26 days p.i. (chronic; n = 4 per group) (C), and mean clinical scores were compared between IL-37-treated mice and control. Clinical scores were analyzed by multiple unpaired t-tests. Mean clinical scores were analyzed by Student’s t-test. Data shown as mean ± SEM. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered significant. Ns: not significant

Article Snippet: Recombinant human IL-37b (rhIL-37b) (R&D Systems) was reconstituted in phosphate-buffered saline (PBS) at 200 μg/mL.

Techniques: Control

Fig. 2 IL-37 enhanced MBP expression. (A) The lumbar section of the spinal cord was harvested from EAE mice treated with PBS (left) or rhIL-37b (middle) at the peak of disease (n = 4 mice in each group). Naïve mice (right) are illustrated as a control to show healthy spinal cord. (B) Mean fluorescent inten sity of MBP expression in both groups was measured using FIJI software. Unpaired t-test was performed to analyze these two groups. Data shown as mean ± SEM. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered significant. Ns: not significant

Journal: Journal of neuroinflammation

Article Title: IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production.

doi: 10.1186/s12974-024-03295-1

Figure Lengend Snippet: Fig. 2 IL-37 enhanced MBP expression. (A) The lumbar section of the spinal cord was harvested from EAE mice treated with PBS (left) or rhIL-37b (middle) at the peak of disease (n = 4 mice in each group). Naïve mice (right) are illustrated as a control to show healthy spinal cord. (B) Mean fluorescent inten sity of MBP expression in both groups was measured using FIJI software. Unpaired t-test was performed to analyze these two groups. Data shown as mean ± SEM. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered significant. Ns: not significant

Article Snippet: Recombinant human IL-37b (rhIL-37b) (R&D Systems) was reconstituted in phosphate-buffered saline (PBS) at 200 μg/mL.

Techniques: Expressing, Control, Software